EHMT2 and neoplasm: EHMT2 is frequently overexpressed, and, in some cases, mutated, and contributes to various malignancies by enhancing cell proliferation, survival, and metastasis through its ability to silence tumor suppressor genes and facilitate oncogenic pathways (Pribluda et al, 2022; Sun et al, 2024; Yang et al, 2024).